XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-based Compensation
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based Compensation

9. Share-based Compensation

Our Third Amended and Restated 2006 Stock Option and Incentive Plan allows for granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, unrestricted stock awards and deferred stock awards to our officers, employees, directors and consultants.

 

The components of share-based compensation expense were as follows:

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2018      2017      2018      2017  
     (in thousands)      (in thousands)  

Stock option awards

   $ 391      $ 310      $ 780      $ 624  

Restricted stock units

     245        161        477        335  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total share-based compensation

   $ 636      $ 471      $ 1,257      $ 959  
  

 

 

    

 

 

    

 

 

    

 

 

 

Stock-based compensation is included in our statements of operations as follows:

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2018      2017      2018      2017  
     (in thousands)      (in thousands)  

Cost of sales

   $ 83      $ 41      $ 148      $ 94  

Sales and marketing

     136        114        273        230  

General and administrative

     351        271        702        546  

Research and development

     66        45        134        89  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation

   $ 636      $ 471      $ 1,257      $ 959  
  

 

 

    

 

 

    

 

 

    

 

 

 

We did not grant any options during the six months ended June 30, 2018. Option grants during the six months ended June 30, 2017 were not material. Awards of restricted stock during the six months ended June 30, 2018 were not material, and we did not issue awards of restricted stock during the six months ended June 30, 2017.

We issued approximately 92,000 and 318,000 shares of common stock following the exercise or vesting of underlying stock options or restricted stock units in the six months ended June 30, 2018 and 2017, respectively.